Myalgisk encefalomyelitis eller kronisk træthedssyndrom

Louise Brinth; Kim Varming; Susanne E Boonen; A C Gonzalez Ebsen; Paula Fernández-Guerra; Anne Sophie Schou; Jesper Mehlsen; Niels Gregersen; Ivan Brandslund; Rikke Katrine Jentoft Olsen

Myalgisk encefalomyelitis eller kronisk træthedssyndrom

Translated title of the contribution: Myalgic encephalomyelitis or chronic fatigue syndrome

Louise Brinth, Kim Varming, Susanne E Boonen, A C Gonzalez Ebsen, Paula Fernández-Guerra, Anne Sophie Schou, Jesper Mehlsen, Niels Gregersen, Ivan Brandslund, Rikke Katrine Jentoft Olsen

Clinical Physiology and Nuclear Medicine

Abstract

In this review, we discuss the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is characterised by extreme mental and physical fatigue with associated symptoms of pain, disturbed sleep, cognitive and autonomic dysfunction, as well as post-exertional malaise. This con-dition is often preceded by an infection, severe physiological and/or psychological strain. Over the last decades, research has demonstrated mitochondrial, neuroendocrine, immuno-logical, and metabolic perturbations in patients with ME/CFS, giving hope for the development of new biomarkers and new treatment modalities.

Translated title of the contribution	Myalgic encephalomyelitis or chronic fatigue syndrome
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	181
Issue number	24
ISSN	0041-5782
Publication status	Published - 10 Jun 2019

Cite this

@article{1d19702cbc8f4ab08e25be13090d8d8a,

title = "Myalgisk encefalomyelitis eller kronisk tr{\ae}thedssyndrom",

abstract = "In this review, we discuss the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is characterised by extreme mental and physical fatigue with associated symptoms of pain, disturbed sleep, cognitive and autonomic dysfunction, as well as post-exertional malaise. This con-dition is often preceded by an infection, severe physiological and/or psychological strain. Over the last decades, research has demonstrated mitochondrial, neuroendocrine, immuno-logical, and metabolic perturbations in patients with ME/CFS, giving hope for the development of new biomarkers and new treatment modalities.",

author = "Louise Brinth and Kim Varming and Boonen, {Susanne E} and Ebsen, {A C Gonzalez} and Paula Fern{\'a}ndez-Guerra and Schou, {Anne Sophie} and Jesper Mehlsen and Niels Gregersen and Ivan Brandslund and Olsen, {Rikke Katrine Jentoft}",

year = "2019",

month = jun,

day = "10",

language = "Dansk",

volume = "181",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "24",

}

TY - JOUR

T1 - Myalgisk encefalomyelitis eller kronisk træthedssyndrom

AU - Brinth, Louise

AU - Varming, Kim

AU - Boonen, Susanne E

AU - Ebsen, A C Gonzalez

AU - Fernández-Guerra, Paula

AU - Schou, Anne Sophie

AU - Mehlsen, Jesper

AU - Gregersen, Niels

AU - Brandslund, Ivan

AU - Olsen, Rikke Katrine Jentoft

PY - 2019/6/10

Y1 - 2019/6/10

N2 - In this review, we discuss the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is characterised by extreme mental and physical fatigue with associated symptoms of pain, disturbed sleep, cognitive and autonomic dysfunction, as well as post-exertional malaise. This con-dition is often preceded by an infection, severe physiological and/or psychological strain. Over the last decades, research has demonstrated mitochondrial, neuroendocrine, immuno-logical, and metabolic perturbations in patients with ME/CFS, giving hope for the development of new biomarkers and new treatment modalities.

AB - In this review, we discuss the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is characterised by extreme mental and physical fatigue with associated symptoms of pain, disturbed sleep, cognitive and autonomic dysfunction, as well as post-exertional malaise. This con-dition is often preceded by an infection, severe physiological and/or psychological strain. Over the last decades, research has demonstrated mitochondrial, neuroendocrine, immuno-logical, and metabolic perturbations in patients with ME/CFS, giving hope for the development of new biomarkers and new treatment modalities.

M3 - Tidsskriftartikel

C2 - 31267953

VL - 181

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 24

ER -

Myalgisk encefalomyelitis eller kronisk træthedssyndrom

Abstract

Fingerprint

Cite this